Related Experiment Video
Updated: Oct 6, 2025

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
Weaning Failure in Critically Ill Patients Is Related to the Persistence of Sepsis Inflammation
Anna Kyriakoudi1, Nikoletta Rovina1, Ourania Koltsida1
11st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens and "Sotiria" Chest Disease Hospital, 11527 Athens, Greece.
Introduction:
Septic patients undergoing mechanical ventilation (MV) often experience difficulty in weaning. Th aim of this study was to determine whether inflammatory biomarkers of sepsis could be indicative of the failure or success of spontaneous breathing trial (SBT) in these patients.
Methods:
Sixty-five patients on MV (42 septic and 23 intubated for other reasons) fulfilling the criteria for SBT were included in the study. Blood samples were collected right before, at the end of (30 min) and 24 h after the SBT. Serum inflammatory mediators associated with sepsis (IL-18, IL-18BP, TNF) were determined and correlated with the outcome of SBT.
Results:
A successful SBT was achieved in 45 patients (69.2%). Septic patients had a higher percentage of SBT failure as compared to non-septic patients (85% vs. 15%, p = 0.026), with an odds ratio for failing 4.5 times (OR = 4.5 95%CI: 1.16-17.68, p 0.022). IL-18 levels and the relative mRNA expression in serum were significantly higher in septic as compared to non-septic patients (p < 0.05). Sepsis was independently associated with higher serum IL-18 and TNF levels in two time-point GEE models (53-723, p = 0.023 and 0.3-64, p = 0.048, respectively). IL-18BP displayed independent negative association with rapid shallow breathing index (RSBI) (95% CI: -17.6 to -4, p = 0.002).
Conclusion:
Sustained increased levels of IL-18 and IL-18BP, acknowledged markers of sepsis, were found to be indicative of SBT failure in patients recovering from sepsis. Our results show that, although subclinical, remaining septic inflammation that sustaines for a long time complicates the weaning procedure. Biomarkers for the estimation of the septic burden and the right time for weaning are needed.
Insights
Sepsis patients on mechanical ventilation have higher rates of spontaneous breathing trial (SBT) failure. Inflammatory markers like IL-18 and IL-18BP indicate a higher risk of weaning failure in these critically ill patients.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Infectious Disease
Background:
- Mechanical ventilation (MV) poses weaning challenges for septic patients.
- Identifying predictors of weaning success is crucial for patient recovery.
Purpose of the Study:
- To investigate inflammatory biomarkers of sepsis as predictors of spontaneous breathing trial (SBT) success or failure.
- To assess the role of serum inflammatory mediators in weaning outcomes for ventilated patients.
Main Methods:
- Sixty-five patients on MV (42 septic, 23 non-septic) underwent SBT.
- Serum samples were collected pre-SBT, post-SBT (30 min), and 24 hours after SBT.
- Levels of Interleukin-18 (IL-18), IL-18 Binding Protein (IL-18BP), and Tumor Necrosis Factor (TNF) were measured and correlated with SBT outcomes.
Main Results:
- Septic patients exhibited a significantly higher SBT failure rate (85%) compared to non-septic patients (15%).
- Elevated serum IL-18 and TNF levels were independently associated with sepsis.
- Higher IL-18 and IL-18BP levels were indicative of SBT failure, with IL-18BP negatively associated with the rapid shallow breathing index (RSBI).
Conclusions:
- Sustained elevated IL-18 and IL-18BP levels predict SBT failure in sepsis survivors.
- Persistent subclinical inflammation in sepsis complicates weaning from mechanical ventilation.
- There is a need for biomarkers to accurately estimate septic burden and determine optimal weaning timing.
Related Concept Videos
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Respiratory Failure-III
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

